R-CHOP in the treatment of DLBCL: Single institution experience from north India.

被引:0
|
作者
Vaid, AK [1 ]
Gupta, S [1 ]
Doval, DC [1 ]
Talwar, V [1 ]
Gupta, R [1 ]
Sharma, JB [1 ]
Chaturvedi, AK [1 ]
Prakesh, N [1 ]
机构
[1] Rajiv Gandhi Canc Inst & Res Ctr, Delhi, India
关键词
D O I
10.1182/blood.V106.11.4773.4773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4773
引用
收藏
页码:273B / 273B
页数:1
相关论文
共 50 条
  • [21] A Propensity Score-Adjusted Comparison of Lenalidomide plus R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients
    de Jonge, A. Vera
    van Werkhoven, Erik D.
    Dinmohamed, Avinash G.
    Nijland, Marcel
    Zwinderman, Aeilko H.
    Bossuyt, Patrick M.
    Veldhuis, Martine S.
    Rutten, Emma G. G. M.
    Mous, Rogier
    Vermaat, Joost S. P.
    Sandberg, Yorick
    de Jongh, Eva
    Bilgin, Yavuz M.
    Boersma, Rinske
    Koene, Harry R.
    Kersten, Marie Jose
    de Jong, Daphne
    Chamuleau, Martine E. D.
    BLOOD, 2022, 140 : 2059 - 2060
  • [22] R-CHOP Plus Bortezomib Unpromising in Patients With DLBCL, While an Early Trial of R-CHOP Plus Everolimus Shows Remarkable Results
    不详
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 9 - 11
  • [23] FOLLICULAR NHL IN TREATMENT WITH R-CHOP AND RITUXIMAB FOR MAINTENANCE, OUR EXPERIENCE
    Nadal Paula, Ortega
    Jose David, Gonzalez San Miguel
    Khoury Cristina, Romero
    Mesa Susej, Guedes
    Maria del Carmen, Losada Castillo
    Martin Manuel, Tapia
    Fuertes Fernando, Fernandez
    Quintana Cristina, Lemes
    Ruiz Ylenia, Morales
    Jose Miguel, Bosch Benitez
    Gomez Mar, Caballero
    HAEMATOLOGICA, 2021, 106 (10) : 297 - 298
  • [24] Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Bantilan, Kurt S.
    Smith, Alexandra N.
    Maurer, Matthew J.
    Teruya-Feldstein, Julie
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Straus, David J.
    Noy, Ariela
    Palomba, M. Lia
    Horwitz, Steven M.
    Hamlin, Paul A.
    Portlock, Carol S.
    Cerhan, James R.
    Habermann, Thomas M.
    Salles, Gilles A.
    Nowakowski, Grzegorz S.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BLOOD ADVANCES, 2024, 8 (09) : 2172 - 2181
  • [25] Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
    Visco, Carlo
    Pregnolato, Francesca
    Ferrarini, Isacco
    De Marco, Beatrice
    Bonuomo, Valentina
    Sbisa, Eugenio
    Fraenza, Costanza
    Bernardelli, Andrea
    Tanasi, Ilaria
    Quaglia, Francesca Maria
    Krampera, Mauro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 163
  • [26] A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
    A. Vera de Jonge
    Erik van Werkhoven
    Avinash G. Dinmohamed
    Marcel Nijland
    Aeilko H. Zwinderman
    Patrick M. Bossuyt
    Martine S. Veldhuis
    Emma G. G. M. Rutten
    Rogier Mous
    Joost S. P. Vermaat
    Yorick Sandberg
    Eva de Jongh
    Yavuz M. Bilgin
    Rinske Boersma
    Harry Koene
    Marie José Kersten
    Daphne de Jong
    Martine E. D. Chamuleau
    Blood Cancer Journal, 13
  • [27] A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution
    Huang, Jia-Jia
    Xia, Yi
    Wang, Yu
    Liu, Pan-Pan
    Bi, Xi-Wen
    Sun, Peng
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Li, Zhi-Ming
    ONCOTARGET, 2016, 7 (27) : 41242 - 41250
  • [28] R-FMD vs R-CHOP treatment as first line therapy for follicular lymphomas: A single center experience
    Dell'Olio, M.
    Bodenizza, C.
    Carella, A. M.
    Falcone, A.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Scalzulli, P.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 470 - 471
  • [29] Routine Prophylaxis of Pneumocystis Pneumonia from the Fourth Cycle of R-CHOP Regimen in DLBCL Patients
    Park, Silvia
    Kim, Seok Jin
    Kim, Won Seog
    BLOOD, 2017, 130
  • [30] Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
    Geng, Hongzhi
    Jia, Sixun
    Zhang, Ying
    Li, Jiaqi
    Yang, Qin
    Zeng, Liangyu
    Zong, Xiangping
    Lu, Yutong
    Lu, Shuangzhu
    Zhou, Jin
    Li, Caixia
    Wu, Depei
    FRONTIERS IN IMMUNOLOGY, 2023, 14